The Mental Activity and eXercise Trial for Seniors

NCT00522899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2012-04-09

No results posted yet for this study

Summary

The primary objective of this study is to conduct a randomized, controlled trial to determine whether engaging in mental activity or exercise, either alone or in combination, improves cognitive function in non-demented, inactive older adults who self-report a recent decline in memory or thinking. In addition, we, the researchers at the University of California, San Francisco, plan to seek funding to follow subjects over time to determine whether these interventions are associated with changes in rate of cognitive decline or risk of dementia after the intervention period has ended.

Conditions

Interventions

BEHAVIORAL

Group 1

Aerobic exercise plus computer-based mental activity training: both 3 days/week, 60 minutes/session for 12 weeks.

BEHAVIORAL

Group 2

Aerobic exercise plus educational DVDs: both 3 days/week, 60 minutes/session for 12 weeks.

BEHAVIORAL

Group 3

Stretching/toning exercise group plus computer-based mental activity training: both 3 days/week, 60 minutes/session for 12 weeks.

BEHAVIORAL

Group 4

Stretching/toning exercise group plus educational DVDs: both 3 days/week, 60 minutes/session for 12 weeks.

Sponsors & Collaborators

Principal Investigators

  • Deborah E Barnes, PhD, MPH · University of California, San Francisco and San Francisco VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-12-31
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00522899 on ClinicalTrials.gov